Julian Howell
Direttore Tecnico/Scientifico/R&S presso Phosphate Therapeutics Ltd.
Profilo
Julian Howell is currently the Group Medical Director at Phosphate Therapeutics Ltd.
He previously worked as an Associate Director-Medical Affairs at Smithkline Beecham Plc, Medical Director & VP-Drug Development at Shield Holdings AG, Group Medical Director at Shield Therapeutics Plc, Clinical Scientist at Roche Pharmaceuticals, Inc., Chief Medical Officer at ReNeuron Group Plc, and Head-Clinical Development & Medical Affairs at Kyowa Kirin International Plc.
Dr. Howell earned an MBA degree from Cranfield University.
Posizioni attive di Julian Howell
Società | Posizione | Inizio |
---|---|---|
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Julian Howell
Società | Posizione | Fine |
---|---|---|
SHIELD THERAPEUTICS PLC | Corporate Officer/Principal | - |
RENEURON GROUP PLC | Direttore Tecnico/Scientifico/R&S | - |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | - |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Julian Howell
Cranfield University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
RENEURON GROUP PLC | Health Technology |
SHIELD THERAPEUTICS PLC | Health Technology |
Aziende private | 5 |
---|---|
Shield Holdings AG
Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Health Technology |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Health Technology |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Julian Howell